(115 days)
Not Found
No
The description focuses on standard electrochemical biosensor technology and basic meter functions (buttons, display). There is no mention of AI, ML, or any features that would suggest their use.
No
A therapeutic device is used to treat or prevent a disease or condition. This device is an in vitro diagnostic device used for monitoring blood glucose levels, aiding in the management of diabetes rather than directly treating it.
Yes
The "Intended Use / Indications for Use" section explicitly states "The FreeStyle Lite Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program by quantitatively measuring glucose in fresh whole blood from the finger, upper arm and palm." This directly indicates its function as a diagnostic aid. While it notes it should not be used for diagnosis or screening of diabetes, its role in monitoring a control program through quantitative measurement of glucose in blood is a diagnostic function.
No
The device description clearly outlines hardware components like a meter with a strip port, buttons, and a display window, indicating it is a physical device, not software-only.
Yes, this device is an IVD (In Vitro Diagnostic).
The Intended Use section explicitly states: "The FreeStyle Lite Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use)..." This directly indicates that the device is designed for diagnostic testing performed outside of the living organism.
N/A
Intended Use / Indications for Use
The FreeStyle Lite Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program by quantitatively measuring glucose in fresh whole blood from the finger, upper arm and palm. The FreeStyle Lite Blood Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use. It is intended to be used by a single person and should not be shared. Alternate site testing should be done only during steady state times (when glucose is not changing rapidly). The FreeStyle Lite Blood Glucose Test Strips are for use with the FreeStyle Lite Blood Glucose Meter to quantitatively measure glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, upper arm and palm.
Product codes (comma separated list FDA assigned to the subject device)
NBW, LFR
Device Description
The FreeStyle Lite Meter, in conjunction with the FreeStyle Lite Test Strips works on the principal of coulometric biosensor technology, measuring glucose by its reaction with Glucose Dehydrogenase (GDH) in blood samples or control solutions, through electrochemical mediation.
The FreeStyle Lite Meter consists of the following major features:
- Strip Port where the FreeStyle Lite Test Strip is inserted. ●
- . Buttons - used to turn the meter on/off and recall information stored in the meter.
- . Display Window - where test results, messages and information stored in the meter appear.
The device is prepared for use by inserting a glucose test strip in the test strip port. Upon strip insertion, the meter will turn on automatically and perform a display check. The meter will then display the time, month and day (if set). The 'apply blood' message is displayed for the user to apply blood to the test strip until the meter begins the test. Blood detect will occur when the meter detects trigger current from the test strip, initiated when enough blood has covered the strip electrodes. Following the blood detect, the meter performs the glucose assay measurement.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
finger, upper arm and palm
Indicated Patient Age Range
Not Found
Intended User / Care Setting
self-testing by people with diabetes at home
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The results obtained from performance studies demonstrate that the FreeStyle Lite Blood Glucose Monitoring System is safe and effective for its intended use and technological characteristics, and therefore, substantially equivalent to the predicate device (K092602).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1345 Glucose test system.
(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around the symbol. The logo is black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 5, 2016
ABBOTT LABORATORIES SAI TATAVARTY REGULATORY AFFAIRS SPECIALIST 1360 SOUTH LOOP ROAD ALAMEDA CA 94502
Re: K150332
Trade/Device Name: FreeStyle Lite Blood Glucose Monitoring System Regulation Number: 21 CFR 862.1345 Regulation Name: Glucose test system Regulatory Class: II Product Code: NBW, LFR Dated: May 7, 2015 Received: May 8, 2015
Dear Sai Tatavarty:
This letter corrects our substantially equivalent of June 02, 2015.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the
1
electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Courtney H. Lias -S
Courtney H. Lias, Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K150332
Device Name
FreeStyle Lite Blood Glucose Monitoring System
Indications for Use (Describe)
The FreeStyle Lite Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program by quantitatively measuring glucose in fresh whole blood from the finger, upper arm and palm. The FreeStyle Lite Blood Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use. It is intended to be used by a single person and should not be shared. Alternate site testing should be done only during steady state times (when glucose is not changing rapidly). The FreeStyle Lite Blood Glucose Test Strips are for use with the FreeStyle Lite Blood Glucose Meter to quantitatively measure glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, upper arm and palm.
| Type of Use ( Select one or both, as applicable ) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | |
| Over-The-Counter Use (21 CFR 801 Subpart C) | ☑ |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
June 4, 2015
Abbott Diabetes Care Inc. 1360 South Loop Road, Alameda, CA 94502
510.749.5105 Tel: Fax: 510.864.4791 sai.tatavarty@abbott.com
Image /page/3/Picture/3 description: The image shows the logo for Abbott, a global healthcare company. The logo consists of a stylized letter 'a' in a bold, sans-serif font. The letter is rendered in a solid blue color and has a rounded, geometric design. The logo is simple, modern, and easily recognizable.
510(k) Summary
According to the requirements per 21 CFR §807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.
| Company: | Abbott Laboratories |
|---|---|
| Division: | Abbott Diabetes Care, Inc. |
| Street Address: | 1360 South Loop Road |
| City, State Zip: | Alameda, CA 94502 |
| Contact Person: | Sai Sriharshada Tatavarty |
| Tel No. 510-749-5105 | |
| Fax No. 510-864-4791 | |
| sai.tatavarty@abbott.com | |
| Proprietary Name: | FreeStyle Lite Blood Glucose Monitoring System |
| Common Name: | Glucose Test System |
| Classification Name: | Glucose Dehydrogenase, Glucose, Class II (21 CFR§ 862.1345) |
| Product codes: NBW,LFR | |
| Predicate Device: | FreeStyle Lite Blood Glucose Test Strips (K092602) |
| Legal Manufacturer: | Establishment: |
| Abbott Diabetes Care Inc. | |
| 1360 South Loop Road | |
| Alameda, CA 94502 |
Image /page/3/Picture/7 description: The image shows the Abbott logo. On the left is a blue abstract symbol that resembles the letter "a". To the right of the symbol is the word "Abbott" in a bold, serif font. Below the word "Abbott" is the tagline "A Promise for Life" in a smaller, sans-serif font.
4
Indications for use:
The FreeStyle Lite Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program by quantitatively measuring glucose in fresh whole blood from the finger, upper arm and palm. The FreeStyle Lite Blood Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use. It is intended to be used by a single person and should not be shared. Alternate site testing should be done only during steady state times (when glucose is not changing rapidly). The FreeStyle Lite Blood Glucose Test Strips are for use with the FreeStyle Lite Blood Glucose Meter to quantitatively measure glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, upper arm and palm.
Description of the Device:
The FreeStyle Lite Meter, in conjunction with the FreeStyle Lite Test Strips works on the principal of coulometric biosensor technology, measuring glucose by its reaction with Glucose Dehydrogenase (GDH) in blood samples or control solutions, through electrochemical mediation.
The FreeStyle Lite Meter consists of the following major features:
- Strip Port where the FreeStyle Lite Test Strip is inserted. ●
- . Buttons - used to turn the meter on/off and recall information stored in the meter.
- . Display Window - where test results, messages and information stored in the meter appear.
The device is prepared for use by inserting a glucose test strip in the test strip port. Upon strip insertion, the meter will turn on automatically and perform a display check. The meter will then display the time, month and day (if set). The 'apply blood' message is displayed for the user to apply blood to the test strip until the meter begins the test. Blood detect will occur when the meter detects trigger current from the test strip, initiated when enough blood has covered the strip electrodes. Following the blood detect, the meter performs the glucose assay measurement.
Principles of Operation:
The FreeStyle Lite Meter (in conjunction with FreeStyle Lite blood glucose test strips) utilizes coulometric biosensor technology to quantitatively measure the glucose concentration in whole blood samples and in FreeStyle Control Solutions.
The FreeStyle Lite Meter measures glucose electrochemically. The glucose biosensor is capable of recognizing the glucose present in whole blood or control solutions by virtue of the glucose specificity of the enzyme glucose dehydrogenase (GDH) present on the glucose test strip. The electrons liberated by this reaction are transferred via a co-factor and mediator to the meter where they are read as a small electrical current is integrated over the analysis time to generate charge which is directly proportional to the level of the glucose in the applied sample.
Image /page/4/Picture/12 description: The image shows the Abbott logo. The logo consists of a blue abstract shape on the left and the word "Abbott" in bold black letters on the right. Below the word "Abbott" is the phrase "A Promise for Life" in a smaller, lighter font.
5
The FreeStyle Lite Meter does not require calibration prior to use with the FreeStyle Lite Test Strips. The device is prepared for use by inserting a FreeStyle Lite test strip in the test strip port. Upon strip insertion, the meter will turn on automatically and perform a display check. The meter will then display the time, month and day (if set). The 'apply blood' message is displayed for the user to apply blood to the test strip until the meter begins the test. Blood detect will occur when the meter detects trigger current from the test strip. initiated when enough blood has covered the strip electrodes. Following the blood detect, the meter performs the glucose assay measurement.
Description of Modification:
The basis for this submission is to incorporate cleaning and disinfection procedures into the FreeStyle Lite System, which may be packaged with the following components and accessories listed below.
- A. FreeStyle Lite Meter
- B. 10 count vial of FreeStyle Lite Test Strips (may be sold separately)
- C. Carrying Case
- D. FreeStyle Lancing Device II Lancing Device
- E. FreeStyle/Thin Lancets
- F. Owner's Booklet
- G. Quick Start Guide
- H. USB Cable
- I. FreeStyle Control Solutions (may be obtained by contacting Customer Service)
Substantial Equivalence:
The FreeStyle Lite Blood Glucose Monitoring System is substantially equivalent to the predicate, which was cleared by the Agency on May 14, 2010, under K092602: FreeStyle Lite Blood Glucose Test Strips. The results obtained from performance studies demonstrate that the FreeStyle Lite Blood Glucose Monitoring System is safe and effective for its intended use and technological characteristics, and therefore, substantially equivalent to the predicate device (K092602).
Image /page/5/Picture/14 description: The image contains the Abbott logo. The logo consists of a stylized letter "A" in blue, followed by the word "Abbott" in bold, black letters. Below the word "Abbott" is the tagline "A Promise for Life" in a smaller, lighter font.
6
Comparison to Predicate Device:
The similarities and differences between the FreeStyle Lite Blood Glucose Monitoring System and the predicate (K092602) are highlighted in the table below.
Similarities:
| PRODUCT NAME | FreeStyle Lite Blood
Glucose Test Strips
(K092602) | Modified FreeStyle Lite
Blood Glucose Monitoring
System (K150332) |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| CHARACTERISTICS | | |
| Indications for Use | The FreeStyle Lite Blood
Glucose Monitoring System is
intended for use in the
quantitative measurement of
glucose in capillary whole
blood from the finger, upper
arm and palm, and venous
whole blood.
The FreeStyle Lite Blood
Glucose Monitoring System is
intended for use by healthcare
professionals and people with
diabetes mellitus at home as an
aid in monitoring the
effectiveness of a diabetes
control program.
The FreeStyle Lite Blood
Glucose Monitoring System is
not intended for the diagnosis
of or screening for diabetes
mellitus, and is not intended for
use on neonates or arterial
blood. | The FreeStyle Lite Blood
Glucose Monitoring System is
intended for self-testing outside
the body (in vitro diagnostic
use) by people with diabetes at
home as an aid in monitoring
the effectiveness of a diabetes
control program by
quantitatively measuring
glucose in fresh whole blood
from the finger, upper arm and
palm. The FreeStyle Lite
Blood Glucose Monitoring
System should not be used for
the diagnosis of or screening of
diabetes or for neonatal use. It
is intended to be used by a
single person and should not be
shared. Alternate site testing
should be done only during
steady state times (when
glucose is not changing
rapidly).
The FreeStyle Lite Blood
Glucose Test Strips are for use
with the FreeStyle Lite Blood
Glucose Meter to quantitatively
measure glucose (sugar) in
fresh capillary whole blood
samples drawn from the
fingertips, upper arm and palm. |
Image /page/6/Picture/4 description: The image shows the Abbott logo. The logo consists of a blue abstract shape on the left and the word "Abbott" in bold, black letters on the right. Below the word "Abbott" is the phrase "A Promise for Life" in a smaller, lighter font.
7
| Classification Product Code | NBW, LFR | Same |
|---|---|---|
| Fundamental Technology | The FreeStyle Lite Meter (in conjunction with blood glucose test strips) utilizes coulometric biosensor technology to quantitatively measure the glucose concentration in whole blood samples and in FreeStyle Control Solutions | Same |
| Enzyme | GDH - FAD | Same |
| Sample Type | Venous or capillary whole blood | Same |
| AST | Upper arm & palm | Same |
| Sample Volume | 0.3 µL | Same |
| Measurement Glucose Range | 20 to 500 mg/dL | Same |
| Measurement Time | average 5 seconds | Same |
| Second sample application | Within 60 seconds | Same |
| Calibration | None | Same |
| Lancet | FreeStyle/Thin Lancets | Same |
| Battery life | 500 tests | Same |
| Hematocrit | 15% to 65% | Same |
| Measurement units | mg/dL | Same |
| Meter storage temperature | - 4° to 140° F (- 20° to 60° C) | Same |
| Memory | 400 blood glucose and control solution tests with date and time | Same |
| Operating relative humidity | 5% to 90% (non-condensing) | Same |
| Operating temperature | 40° to 104° F (4° to 40° C) | Same |
| Power Source | One CR 2032, 3V lithium battery, replaceable | Same |
Image /page/7/Picture/1 description: The image shows the Abbott logo. The logo consists of a stylized letter 'A' in blue, followed by the word 'Abbott' in bold, black letters. Below the word 'Abbott' is the tagline 'A Promise for Life' in a smaller font size.
8
Differences:
| PRODUCT NAME | FreeStyle Lite Blood
Glucose Test Strips
(K092602) | Modified FreeStyle Lite
Blood Glucose Monitoring
System (K150332) |
|---------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| CHARACTERISTICS | | |
| Meter cleaning and disinfection | Clean with:
Mild detergent/soap and water, or 70% isopropyl alcohol, or A mixture of 1 part household bleach, 9 parts water | 522 cleaning and 522
disinfection cycles (the
equivalent of 2 cycles per
week for 5 years) with
Clorox Healthcare Bleach
Germicidal Wipes, EPA Reg.
#67619-12 |
| Lancing device cleaning and
disinfection | Clean with:
Isopropyl alcohol or Soap and water or Warm water | 210 cleaning and 210
disinfection cycles (the
equivalent of 2 cycles per
week for 2 years) with
Clorox Healthcare Bleach
Germicidal Wipes, EPA Reg.
#67619-12 |
| Lancing device | FreeStyle Lancing Device | FreeStyle Lancing Device-II |
Image /page/8/Picture/2 description: The image contains the Abbott logo. The logo consists of a stylized blue "A" symbol on the left and the word "Abbott" in bold, black letters on the right. Below the word "Abbott" is the tagline "A Promise for Life" in a smaller, lighter font.